Biopharma and medtech companies trust BrightInsight’s compliant platform to differentiate and expand the value of their therapies with groundbreaking digital solutions. SaMD is the backbone of next-generation companion apps, dosing and treatment selection algorithms, data analytics and more. Learn how SaMD is transforming healthcare.
Digital enables more engaging patient experiences by increasing therapy compliance, improving disease and medical tracking and as importantly, building connections among patients and with healthcare providers. The data collected with digital can be used to deliver more personalized therapies, increase reimbursement and potentially increase revenues through extended patent life."
– Brad Gescheider, Global Head, Digital Innovation and Patient Services, Immunology at Sanofi
Insights from top digital health executives on how to speed time to market and lower costs for SaMD solutions.
Read the White Paper
Roche developed a digital dosage calculator to aid prescribing physicians and maximize Hemlibra’s therapeutic benefits for patients with Hemophilia A. Rather than engineer their own infrastructure, applications and data stores, Roche partnered with BrightInsight and significantly accelerated time to market.
Read the Case Study
While the potential applications for SaMD are myriad, a recent survey found that disease management was the most promising use case.
This new guidance from the FDA has important information for anyone operating in the digital health space.
Learn More
Learn more about how Roche launched a CE-marked dosing calculator to treat Hemophilia A in just 6 months in this conversation with Paul Upham, Head of Smart Devices at Roche/Genentech.
Watch
Contact us to set up a demo today.